Firm Logo
215-608-9645

Blog

  • Informed Consent and Depo-Provera: Are Women Being Properly Informed?

    Oct 7, 2024

    Women deserve the right to make choices about their health, but only through full and accurate warnings and drug information can any woman make the decision that’s right for her. Women who aren’t properly informed about the risks of their birth control medications could be taking on serious health risks without even knowing it. That, along with the severe harm that has been linked to birth control injections in the form of an increased risk...
    Read More
  • Lawsuit for Depo Provera: Pfizer Hid the Ugly Truth from Women

    Oct 6, 2024

    Kila Baldwin is one of the leaders of the Anapol Weiss Women's Health Litigation Team, which is advancing a lawsuit for Depo Provera injuries. Kila is currently investigating cases of women who used Depo-Provera and developed brain or spinal cord tumors (meningiomas). Lifestyle drugs are medications prescribed not to treat an illness, but rather to help in your lifestyle. Millions of women for decades have taken prescribed birth control medications to avoid getting pregnant. There...
    Read More
  • Could Tumors Caused by Depo-Provera Have Been Avoided by a Safer Version Owned by Pfizer?

    Oct 5, 2024

    Shayna Slater, Anapol Weiss Women’s Health Ligitation Team Depo-Provera, a popular hormonal contraceptive, has been a go-to choice for many seeking birth control. Administered via injection every three months, it purported to offer convenience and effectiveness. However, there is now evidence that it also increased women’s risk of brain and spinal tumors, called meningiomas. A Safer Alternative Sadly, initial research suggests that Pfizer actually owned a safer alternative. While investigation continues, if Pfizer did, in fact, own a...
    Read More
  • Health Implications: How the Depo-Provera Lawsuit Highlights Women's Health Concerns

    Oct 4, 2024

    The birth control shot, a contraceptive delivered by injection every 12 weeks, has been hailed as a convenient alternative for women who don’t want to take birth control pills daily. Unfortunately, recent research findings have raised serious concerns about the safety of this medication. The recent Depo-Provera lawsuits are the latest mass tort legislation arising out of women’s health concerns. For patients who did or currently do use Depo-Provera for birth control, it’s important to understand...
    Read More
  • Fighting for Women and Infants - That's What Motivates Me

    Oct 4, 2024

    [Excerpt from a conversation with Paola Pearson, a Partner on the Anapol Weiss Women's Health Litigation Team] In 2021, I gave birth to a healthy baby girl after years of fertility challenges. My experience with pregnancy and loss inspire my career as an attorney in ways I never imagined. Birth Injuries Caused by Negligence My personal fight to become a mother motivates me to fight for the victims of senseless birth injuries that result in preventable and catastrophic...
    Read More
  • Depo Shot Lawsuit: Yet Another Example of Women Fighting Back Against Harmful Drugs

    Oct 4, 2024

    By: Anapol Weiss Women’s Health Litigation Team Depo-Provera, the popular injectable contraceptive containing medroxyprogesterone acetate, has been marketed as a safe, convenient, long-term birth control solution. However, recent research has linked it to an increased risk of brain and spinal cord tumors (“meningiomas”), resulting in the filing of Depo shot lawsuit claims. If you have been diagnosed with a brain tumor after using Depo-Provera, you may have legal recourse through the Depo Provera class action lawsuit...
    Read More
  • Representing Women Catastrophically Injured by Transvaginal Mesh Implants

    Oct 3, 2024

    Excerpt from a conversation with Kila Baldwin, who has secured over $180 million in settlements for women injured by transvaginal mesh implants. Kila is one of the leaders of the Anapol Weiss Women's Health Litigation Team. I have tried cases for many women who were catastrophically injured by transvaginal mesh. Medical device manufacturers, like Johnson & Johnson, Boston Scientific, Bard, and Coloplast marketed and sold transvaginal mesh for the treatment of pelvic organ prolapse (POP) and...
    Read More
  • Consequences of Nurse Understaffing at Nursing Homes

    Oct 2, 2024

    Having enough nursing staff at a nursing home is crucial to ensuring that the home’s residents get the care and treatment they need. Fortunately, Pennsylvania has enacted a state minimum for nursing home staff levels, and that minimum just increased beginning July 1, 2024. Now, Pennsylvania nursing homes are required to have enough nursing staff to provide 3.2 hours PPD, or “per patient day. ” This is up from 2.87 PPD as of July 1,...
    Read More
  • Recreational Helmets: Design Defects—Bicycle, Football and Motorcycling

    Sep 30, 2024

    Published in The Legal Intelligencer September 30, 2024 By Larry Coben, Anapol Weiss Excerpts from the article: No one has ever attempted any sort of retrospective study of the relationship between helmet design and the frequency or nature of injury. And yet the issue of the efficacy of helmet safety effects millions of Americans. Approximately 47 million Americans bicycle on a regular basis. In 2015, in the United States, over 1,000 bicyclists died and there were almost 338,000 bicycle-related injuries...
    Read More
  • Female Patients at Jefferson Health Hospital are Forced to Cope with the Consequences of Incorrect Mammogram Result Failures

    Sep 26, 2024

    Jefferson Einstein Philadelphia, formerly Einstein Medical Center, was recently cited by local health inspectors for providing incorrect mammogram results to patients. Sarah Gantz authored an article for the Philadelphia Inquirer dated September 26, 2024, wherein she describes how Jefferson Einstein (“Einstein”) incorrectly informed patients their mammogram results showed “no sign of breast cancer.” However, these patients subsequently learned the results were inconclusive requiring follow-up. This news comes after at least two women have reported receiving incorrect...
    Read More